U.S., July 23 -- An application to own the trademark for 'IMOSIPA VICI' has been filed on Oct. 24, 2024.
Owner(s):
TEVA PHARMACEUTICALS USA, Inc.; 400 Interpace Parkway, Building A, NEW JERSEY
Goods and/or Services:
For: Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases by prescription only
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-07-22&serialNumber=98818008
Disclaimer: Curated by HT Syndication....